Endocrine analytes in multiple-marker screening

Clinics in Perinatology

Volumn 25, Issue 4, 1998, Pages 963-901

  Lambert Messerlian, G M ^a   Canick, J A ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; PROTEIN A;

BLOOD ANALYSIS; DIAGNOSTIC VALUE; DISEASE MARKER; ENDOCRINE SYSTEM EXAMINATION; FETUS DEVELOPMENT; GESTATIONAL AGE; HORMONE BLOOD LEVEL; HUMAN; MATERNAL AGE; PRENATAL DISORDER; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW;

EID: 0031791949     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-5108(18)30092-7     Document Type: Review

References (95)

1. Abe Y. Hasegawa Y. Miyamoto High concentrations of plasma immunoreactive inhibin during normal pregnancy J Clin Endocrinol Metab 71 1990 133 137
2. ACOG Committee Opinion: Committee on Obstetric Practice: Down syndrome screening. 141:1–4, 1994
3. Aitken D.A. Wallace E.M. Crossley J.A. Dimeric inhibin-A as a marker for Down’s syndrome in early pregnancy N Engl J Med 334 1996 1231 1236
4. Bock J.L. Current issues in maternal serum alpha-fetoprotein screening Am J Clin Pathol 97 1992 541 554
5. Bogart M. Pandian M.R. Jones O.W. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities Prenat Diagn 7 1987 623 630
6. Bradley L.A. Canick J.A. Palomaki G.E. Undetectable maternal serum unconjugated estriol levels in the second trimester: Risk of perinatal complications associated with placental sulfatase deficiency Am J Obstet Gynecol 176 1997 531 535
7. Brock D.J.H. Sutcliffe R.G. Alpha-fetoprotein in the antenatal diagnosis of anencephaly and spina bifida Lancet 2 1972 197 199
8. Canick J.A. Kellner L.H. Sailer D.N. Second trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy Prenat Diagn 15 1995 739 744
9. Canick J. Knight G.J. Palomaki G.E. Low second trimester maternal serum unconjugated estriol in pregnancies with Down’s syndrome Br J Obstet Gynaecol 95 1988 330 333
10. Canick J.A. Lambert-Messerlian G.M. Palomaki G.E. Maternal serum dimeric inhibin is elevated in Down syndrome pregnancy Am J Hum Genet 55 1994 A9
11. Canick J.A. Palomaki G.E. Osathanondh R. Prenatal screening for trisomy 18 in the second trimester Prenat Diagn 10 1990 546 548
12. Casey M.L. MacDonald P.C. Simpson E.R. Endocrinological changes in pregnancy Wilson J.D. Foster D.W. Williams Textbook of Endocrinology 1992 WB Saunders Philadelphia 977 992
13. Chard T. Biochemistry and endocrinology of the Down’s syndrome pregnancy Ann NY Acad Sei 626 1991 580 596
14. Cole L.A. Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites Clin Chem 43 1997 2233 2243
15. Cole L.A. Acuna A. Isozaki T. Combining β-core fragment and total oestriol measurement to test for Down syndrome pregnancies Prenat Diagn 17 1997 1125 1134
16. Cuckle H.S. Canick J.A. Kellner L.H. Urinary β-core-hCG screening in the first trimester Prenat Diagn 16 1996 1057 1059
17. Cuckle H.S. Holding S. Jones R. Maternal serum inhibin levels in second-trimester Down’s syndrome pregnancies Prenat Diagn 14 1994 387 390
18. Cuckle H.S. Holding S. Jones R. Maternal serum dimeric inhibin A in second-trimester Down’s syndrome pregnancies Prenat Diagn 15 1995 385 392
19. Cuckle H. Iles R.K. Chard T. Urinary β-core human chorionic gonadotropin: A new approach to Down’s syndrome screening Prenat Diagn 14 1994 953 958
20. Cuckle H.S. Iles R.K. Sehmi I.K. Urinary multiple marker screening for Down’s syndrome Prenat Diagn 15 1995 745 751
21. Cuckle H.S. Wald N.J. Amniotic fluid AFP levels and Down syndrome Lancet 1 1985 290 291
22. Cuckle H.S. Wald N.J. Densem J.W. Second trimester amniotic fluid oestriol, dehydroepiandrosterone sulphate, and human chorionic gonadotropin levels in Down’s syndrome Br J Obstet Gynaecol 98 1991 1160 1162
23. Cuckle H.S. Wald N.J. Lindenbaum R.H. Cord serum alpha-fetoprotein and Down’s syndrome Br J Obstet Gynaecol 93 1986 408 410
24. Dejong F.H. Inhibin Physiol Rev 68 1988 555 607
25. DeKretser D.M. Robertson D.M. The isolation and physiology of inhibin and related proteins Biol Reprod 40 1989 33 47
26. Eldar-Geva T. Hochberg A. deGroot N. High maternal serum chorionic gonadotropin level in Downs’ syndrome pregnancies is caused by elevation of both subunits messenger ribonucleic acid level in trophoblasts J Clin Endocrinol Metab 80 1995 3528 3531
27. Fang J. Yin W. Smiley E. Molecular cloning of the mouse activin beta E subunit gene Biochem Biophys Res Commun 228 1996 669 674
28. Gitlin D. Normal biology of α-fetoprotein: I. Biology of α-fetoprotein Ann NY Acad Sei 259 1975 7
29. Golbus M.S. Development in the first half of gestation of genetically abnormal human fetuses Teratology 18 1978 333 336
30. Greenberg F. Faucett A. Rose E. Congenital deficiency of α-fetoprotein Am J Obstet Gynecol 167 1992 509 511
31. Haddow J.E. Palomaki G.E. Knight G.J. Screening of maternal serum for fetal Down’s syndrome in the first trimester N Engl J Med 338 1998 955 961
32. c chain Biochem Biophys Res Commun 206 1995 608 613
33. Hyett J.A. Sebire N.J. Snijders R.J.M. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness Ultrasound Obstet Gynecol 7 1996 101 103
34. Illingworth P.J. Groome N.P. Duncan W.C. Measurement of circulating inhibin forms during the establishment of pregnancy J Clin Endocrinol Metab 81 1996 1471 1475
35. Isozaki T. Palomaki G.E. Bahado-Singh R.O. Screening for Down syndrome pregnancy using β-core fragment: Prospective study Prenat Diagn 17 1997 407 413
36. Kellner L.H. Canick J.A. Palomaki G.E. Levels of urinary beta-core fragment, total oestriol, and the ratio of the two in second-trimester screening for Down syndrome Prenat Diagn 17 1997 1135 1141
37. Kellner L.H. Canick J.A. Palomaki G.E. Maternal urine screening for fetal Down syndrome: Comparison of beta-core fragment, free β subunit and hCG Am J Obstet Gynecol 174 1996 446A
38. Knight G.J. Palomaki G.E. Haddow J.E. Maternal serum levels of the placental products hCG, hPL, SP1 and progesterone are all elevated in cases of Down syndrome Am J Hum Genet 45 1989 A263
39. Knight G.J. Palomaki G.E. Neveux L. hCG and the free β subunit as screening tests for Down syndrome Prenat Diagn 18 1998 235 245
40. Kornman L.H. Morssink L.P. Beekhuis J.R. Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice Prenat Diagn 16 1996 797 805
41. Kornman L.H. Morssink L.P. Wortelboer M.J.M. Maternal urinary β-core hCG in chromosomally abnormal pregnancies in the first trimester Prenat Diagn 17 1997 135 139
42. Kronquist K.E. Dreazen E. Keener S.L. Reduced fetal hepatic alpha-fetoprotein levels in Down’s syndrome Prenat Diagn 10 1990 739 751
43. Lambert-Messerlian G.M. Canick J.A. Palomaki G.E. Second trimester levels of maternal serum inhibin A, total inhibin, α inhibin precursor, and activin in Down’s syndrome pregnancy J Med Screen 3 1996 58 62
44. Lambert-Messerlian G.M. Isaacson K. Crowley W.F. Jr. Human follicular fluid contains pro- and C-terminal immunoreactive α-inhibin precursor proteins J Clin Endocrinol Metab 78 1994 433 439
45. Lambert-Messerlian G.M. Luisi S. Florio P. Second trimester levels of maternal serum total activin A and placental inhibin/activin α and βA subunit messenger ribonucleic acids in Down syndrome pregnancy Eur J Endocrinol 138 1998 425 429
46. Lau H.L. Linkins S.E. Alpha-fetoprotein Am J Obstet Gynecol 124 1976 533
47. Lindenbaum R.H. Ryynanen M. Holmes-Siedle M. Trisomy 18 and maternal serum and amniotic fluid alpha-fetoprotein Prenat Diagn 7 1987 511 519
48. Macintosh M.C.M. Nicolaides K.H. Noble P. Urinary β-core hCG: Screening for aneuploidies in early pregnancy (11–14 weeks gestation) Prenat Diagn 17 1997 401 405
49. Macri J.N. Anderson R.W. Krantz D.A. Prenatal maternal dried blood screening with alpha-fetoprotein and free β-human chorionic gonadotropin for neural tube defect and Down syndrome Am J Obstet Gynecol 174 1996 566 572
50. Macri J.N. Kasturi R.V. Krantz D.A. Maternal serum Down syndrome screening: Unconjugated estriol is not useful Am J Obstet Gynecol 162 1990 672 673
51. Macri J.N. Kasturi R.V. Krantz D.A. Maternal serum Down syndrome screening: Free β-protein is a more effective marker than human chorionic gonadotropin Am J Obstet Gynecol 163 1990 1248 1253
52. Mason A.J. Structure and recombinant expression of human inhibin and activin Hodgen G.D. Rosenwaks Z. Spieler J.M. Nonsteroidal Gonadal Factors: Physiological Roles and Possibilities in Contraceptive Development 1988 Jones Institute Norfolk 19 29
53. McCullagh D.R. Dual endocrine activity of the testes Science 76 1932 19 20
54. McLachlan R.I. Healy D.L. Robertson D.M. The human placenta: A novel source of inhibin Biochem Biophys Res Commun 140 1986 485 490
55. Merchenthaler I. Culler M.D. Petruz P. Immimohistochemical localization of inhibin in rat and human reproductive tissues Mol Cell Endocrinol 54 1987 239 243
56. Merkatz I.R. Nitowsky H.M. Macri J.N. An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities Am J Obstet Gynecol 148 1984 886 894
57. Α dimer) during human pregnancy Clin Endocrinol 42 1995 391 397
58. Newby D. Aitken D.A. Crossley J.A. Biochemical markers of trisomy 21 and the pathophysiology of Down’s syndrome pregnancies Prenat Diagn 17 1997 941 951
59. Nicolaides K.H. Sebire N.J. Snijders R. Down’s syndrome screening in the UK Lancet 347 1996 906 907
60. O’Connor J.F. Schlatterer P.E. Birken S. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its β-subunit, and β-core fragment in the urine: Application to malignancies Cancer Res 48 1988 1361 1366
61. Oxvig C. Sand O. Kristensen T. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein Biochim Biophys Acta 1202 1994 415 423
62. Oyer C.E. Canick J.A. Materal serum hCG levels in triploidy: Variability and need to consider molar tissue Prenat Diagn 12 1992 627 629
63. Palomaki G.E. Knight G.J. Haddow J.E. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin Prenat Diagn 12 1992 925 930
64. Palomaki G.E. Knight G.J. McCarthy J.E. Maternal serum screening for Down syndrome in the United States: A 1995 survey Am J Obstet Gynecol 176 1997 1046 1051
65. Palomaki G.E. Neveux L.M. Haddow J.E. Can reliable Down’s syndrome detection rates be determined from prenatal screening intervention trials? J Med Screen 3 1996 12 17
66. Penrose L.S. The relative effects of paternal and maternal age in mongolism J Genetics 27 1933 219
67. Petraglia F. Garuti G.C. Calza L. Inhibin subunits in human placenta: Localization and messenger ribonucleic acid levels during pregnancy Am J Obstet Gynecol 165 1991 750 756
68. Petraglia F. Luisi S. Benedetto M. Changes in dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases J Clin Endocrinol Metab 82 1997 2991 2995
69. Petraglia F. Sawcherrko P.A. Lim A.T.W. Localization, secretion and action of inhibin in human placenta Science 237 1987 187 189
70. Petraglia F. Woodruff T.K. Botticelli G. Gonadotropin-releasing hormone, inhibin and activin in human placenta: Evidence for a common cellular localization J Clin Endocrinol Metab 74 1992 1184 1188
71. Qu J. Thomas K. Inhibin and activin production in human placenta Endocr Rev 16 1995 485 507
72. Reynolds T. John R. Comparison of assay kits for unconjugated estriol shows that expressing results as multiples of the median causes unacceptable variation in calculated risk factors for Down syndrome Clin Chem 38 1992 1888 1893
73. Roberts L.J. Bewley S. Mackinson A.M. First trimester fetal nuchal translucency: Problems with screening the general population Br J Obstet Gynaecol 2 1995 381 385
74. Robertson D. Burger H.G. Sullivan J. Biological and immunological characterization of inhibin forms in human plasma J Clin Endocrinol Metab 81 1996 669 676
75. Robertson D.M. Giacometti Foulds L.M. Isolation of inhibin ct-subunit precursor proteins from bovine follicular fluid Endocrinology 125 1989 2141 2149
76. Sailer D.N. Jr. Canick J.A. Schwartz S. Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome Am J Obstet Gynecol 167 1992 1021 1024
77. Shepard T.H. FitzSimmons J.M. Fantel A.G. Placental weights of normal and aneuploid early human fetuses Pediatr Pathol 9 1989 425 431
78. Sherer D.M. Bombard A.T. Kellner L.H. Noninvasive first-trimester screening for fetal aneuploidy Obstet Gynecol Surv 52 1997 123 129
79. Spencer K. Aitken D.A. Macri J.N. Urine free beta hCG and beta core in pregnancies affected by Down’s syndrome Prenat Diagn 16 1996 605 613
80. Spencer K. Wood P.J. Anthony F.W. Elevated levels of maternal serum inhibin immuno-reactivity in second trimester pregnancies affected by Down’s syndrome Ann Clin Biochem 30 1993 219 220
81. Thomas R.L. Blakemore K.J. Evaluation of elevations in maternal serum alpha-fetoprotein: A review Obstet Gynecol Surv 45 1980 269 283
82. Vale W. Rivier C. Hseuh A. Chemical and biological characterization of the inhibin family of proteins Recent Prog Horm Res 44 1988 1 34
83. Valenti C. Schutta E.J. Kehaty T. Prenatal diagnosis of Down’s syndrome Lancet 2 1968 220
84. Van Lith J.M.M. Pratt J.J. Beekhuis J.R. Second-trimester maternal serum immunore-active inhibin as a marker for fetal Down’s syndrome Prenat Diagn 12 1992 801 806
85. Verloes A. Schoo R. Herens C. A prenatal trisomy 21 screening programme using alpha-fetoprotein, human chorionic gonadotropin, and free estriol assays on maternal dried blood Am J Obstet Gynecol 172 1995 167 174
86. Wald N.J. Guidance on terminology J Med Screen 1 1994 76
87. Wald N.J. Cheng R. Cuckle H.S. Maternal serum levels of the estriol precursor, 16 a OHDHEAS, are low in Down syndrome pregnancy Am J Hum Genet 51 1992 A1046
88. Wald N.J. Cuckle H.S. Densem J.W. Maternal serum screening for Down’s syndrome in early pregnancy BMJ 297 1988 883 887
89. Wald N.J. Cuckle H.S. Densem J.W. Maternal serum unconjugated oestriol as an antenatal screening test for Down’s syndrome Br J Obstet Gynaecol 95 1988 334 341
90. Wald N.J. Densem J.W. Smith D. Klee G.G. Four marker serum screening for Down’s syndrome Prenat Diagn 14 1994 707 716
91. Wald N.J. Hackshaw A.K. Combining ultrasound and biochemistry in first-trimester screening for Down’s syndrome Prenat Diagn 17 1997 821 829
92. Wald N.J. Kennard A. Hackshaw A. Antenatal screening for Down’s syndrome J Med Screen 4 1997 181 246
93. Wald N.J. Watt H.C. George L. Maternal serum inhibin-A in pregnancies with insulin-dependent diabetes mellitus: Implications for screening for Down’s syndrome Prenat Diagn 16 1996 923 926
94. Watt H.C. Wald N.J. George L. Maternal serum inhibin-A levels for twin pregnancies: Implications for screening for Down’s syndrome Prenat Diagn 16 1996 927 929
95. Watt H.C. Wald N.J. Smith D. Effect of allowing for ethnic group in prenatal screening for Down’s syndrome Prenat Diagn 16 1996 691 698